AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough

Recruitingn/aAges 18 Years - anyAllHull University Teaching Hospitals NHS Trust
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cough has previously been described by the type of cough you have ie such as wet, dry, and chesty, and also by its features such as how often you are coughing its,intensity, and severity, but never has the varying patterns of cough been studied in any detail and it could be that the pattern of the cough is closely related to patient-perceived intensity, frequency and most importantly severity. Cough is a symptom and like any other symptom (such as pain) the severity of it can only be gauged by the patient experiencing it. We have created a one-page brand newl questionnaire that shows 4 distinct cough patterns that we believe exist and an empty field designed so that patients can record a pattern of cough they experience which is not already a choice on the questionnaire. The questionnaire also records patients' experience of how frequent, and intense, the cough is, and how it disrupts t

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Male and female patients \> 18yrs of age 2. Patients with a current cough of at least 8 weeks duration 3. Patients with a clear chest X-Ray within previous 2 yrs 4. Non- smoker 5. Able to understand and comply with the requirements of the study and sign Informed Consent forms. 6. Good understanding of written and spoken English - Exclusion Criteria: 1. Recent respiratory tract infection (\<4 weeks prior). 2. Current smokers or ex-smokers with \<6 months' abstinence prior to Study. 3. Any clinically significant or unstable medical or psychiatric condition that would, in the opinion of the investigator, interfere with the subject's ability to participate in the study safely. 4. Participation in any clinical research study evaluating an investigational drug or therapy within 30 days or within 5 half-lives (whichever is longer) of the investigational drug prior to Study visit. If the subject was in an observational clinical study no washout is required. 5. Subjects who, in the opinion of the Investigator, should not participate in the study for any other reason.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Redspiratory Medicine, First Floor, Daisy Building, Castle Hill Hospital
Cottingham, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy